Puma Growth Holdings, Rubicon Founders affiliates and Adam Boehler hold 6472513.00 Privia Health shares, equal to 5.07% of the common stock, in an activist position. The investors say they will continually review the Investment and communicate with Privia officers, directors, stockholders and third parties, giving investors a defined engagement focus.
Key Highlights
- Approximately $138,436,812 was used to purchase the Privia Health common stock.
- The 5.07% ownership calculation uses 127,734,207 shares outstanding as of July 31, 2026.
- The investors acquired the stake for investment purposes and described the shares as an attractive investment opportunity.
Puma Growth Holdings, LLC and its Rubicon Founders affiliates hold 6,472,513 shares of Privia Health Group, Inc. (NASDAQ: PRVA), representing 5.07% of the common stock. Adam Boehler is included among the reporting persons. The investors said they acquired the shares for investment purposes and intend to keep reviewing the investment.
Ownership Structure Behind Stake
Puma Growth Holdings owns the reported Privia Health shares. Each reporting person is associated with the same 6472513-share position and 5.07% beneficial ownership figure. The percentage was calculated against 127,734,207 Privia Health common shares outstanding as of July 31, 2026.
Purchase Capital and Listed Trading
Approximately $138,436,812 was used to acquire the Privia Health common stock, excluding brokerage commissions. The transaction table includes a sale of 100,000 shares at $27.21 per share on July 7, 2026. The investors originally acquired the common stock because they considered it an attractive investment opportunity. The investors intend to review their Privia Health investment on a continuing basis.
FAQs
Q: Who holds the activist stake in Privia Health?
A: Puma Growth Holdings, Rubicon Founders affiliates and Adam Boehler are the reporting persons behind Privia Health’s activist stake. They are associated with 6,472,513 common shares.
Q: What does the Privia Health activist stake mean for investors?
A: The investors intend to review their position continually and communicate with Privia Health officers, directors, stockholders and third parties. The stated purpose is investment.
Q: How much did Puma Growth spend on Privia Health shares?
A: Approximately $138,436,812 was used to purchase the Privia Health common stock, excluding brokerage commissions. The investors used working capital for the acquisitions.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.